Company news
Conneqt Health Limited (ASX:CQT) news
Conneqt Health Limited news releases on 6ix. Latest, Nov 20, 2023: Finance Facility and Creditor Restructure Update
Press releases — page 2
Finance Facility and Creditor Restructure Update
November 20, 2023
Funding and Capital Update
November 8, 2023
CardieX - Go-to-Market (GTM) & Product Development Update
October 9, 2023
Corporate & Operating Update
October 4, 2023
Corporate Presentation
September 29, 2023
Suspension from Official Quotation
September 28, 2023
Withdrawal of F-1 Registration Statement
September 27, 2023
Convertible Note Facility Update
September 12, 2023
Nasdaq IPO & Dual Listing Update
August 31, 2023
CardieX Files Form F-1 to Dual List on US Nasdaq Exchange
July 26, 2023
Convertible Note Facility and Dual Listing Update
June 30, 2023
Corporate Update
June 29, 2023
CardieX receives FDA 510(k) Clearance for CONNEQT Pulse
April 26, 2023
CardieX Completes Capital Raising
February 9, 2023
CardieX Announces Significant New Clinical Trial Agreement
December 9, 2022
CardieX Acquires Core Assets from Blumio, Inc
November 16, 2022
CardieX Completes Placement & Intended Launch of SPP
August 22, 2022
CardieX Corporate Investor Presentation
August 18, 2022
CardieX Submits FDA Application for CONNEQT Pulse
June 28, 2022
FDA Update for CONNEQT Companion App
May 18, 2022
Mobvoi launches TicWatch GTH Pro with Arty
March 1, 2022
New Clinical Trial with Andwin, Syneos & Philip Morris
February 13, 2022
Notice of Extraordinary General Meeting/Proxy Form
January 14, 2022
Results of CDXO and November Options Exercise Conversions
December 5, 2021
Appendix 4C and Quarterly Activities Report
October 31, 2021
Manufacturing Agreement with Fenda Technology for CONNEQT
October 6, 2021
Clinical Trial Contract Expansion & Increases with Bayer AG
August 25, 2021
CDXs CONNEQT Signs Strategic Collaboration with LifeQ
June 22, 2021
CardieX Corporate Update and Consumer Brand Launch
May 16, 2021
CardieX Granted New Patent for Blood Pressure Measurement
May 11, 2021
CardieX Limited Appendix 4D and Half Year Report
February 26, 2021
Response to ASX Price Query
January 19, 2021
CardieX Half Year Sales and Corporate Update
December 15, 2020
Share Purchase Plan Announced
December 3, 2020
CardieX September Quarter Appendix 4C
October 30, 2020
Commercial Partnership with Mobvoi for New Health Smartwatch
September 24, 2020
CardieX Granted New Blood Pressure Patent
September 18, 2020
Response to ASX Accounts Query
September 15, 2020
Andon Partnership to Manufacture Next Gen of ATCOR Products
September 7, 2020
Appendix 4E and 2020 Annual Report
August 31, 2020
CardieX June Quarter Appendix 4C
July 30, 2020
CardieX June 2020 Quarterly Activity Report
July 29, 2020
Proposed issue of Securities - CDX
July 27, 2020
CardieX Successfully Completes Placement to New Investors
July 26, 2020
Restructure of inHealth Investment & Collaboration Agreement
July 6, 2020
Cleansing Notice
July 2, 2020
CEO Report on CardieX Strategy and Commercial Developments
May 4, 2020
Major Milestone Development of Wearable Sensor Technology
April 24, 2020
CardieX Expansion of Bayer Clinical Trial & Revenue
March 26, 2020
Appendix 4D
February 28, 2020